142 related articles for article (PubMed ID: 10566031)
1. Teriparatide. LY 333334, MN 10T, parathyroid hormone (1-34), parathyroid hormone (1-34)-Asahi, parathyroid hormone (1-34)-Eli Lilly, parathyroid hormone (1-34)-Rhône-Poulenc Rorer, teriparatide acetate, hPTH 1-34, Parathar.
Drugs R D; 1999 Mar; 1(3):222-4. PubMed ID: 10566031
[No Abstract] [Full Text] [Related]
2. Teriparatide for postmenopausal osteoporosis.
Drug Ther Bull; 2004 Dec; 42(12):93-5. PubMed ID: 15587764
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of osteoporosis with PTH].
Takeuchi Y
Clin Calcium; 2014 Jun; 24(6):893-902. PubMed ID: 24870841
[TBL] [Abstract][Full Text] [Related]
4. ALX 111. ALX1-11, PTH, parathyroid hormone (1-84)-Allelix, recombinant human parathyroid hormone, rhPTH(1-84).
Drugs R D; 1999 Mar; 1(3):211-2. PubMed ID: 10566026
[No Abstract] [Full Text] [Related]
5. Recombinant human parathyroid hormone.
Reeve J
BMJ; 2002 Feb; 324(7335):435-6. PubMed ID: 11859030
[No Abstract] [Full Text] [Related]
6. Parathyroid hormone analogues in the therapy of osteoporosis.
Müller M; Pietschmann P
Wien Klin Wochenschr; 2008; 120(11-12):321-4. PubMed ID: 18709518
[No Abstract] [Full Text] [Related]
7. Anabolic therapies for osteoporosis.
Uihlein AV; Leder BZ
Endocrinol Metab Clin North Am; 2012 Sep; 41(3):507-25. PubMed ID: 22877427
[TBL] [Abstract][Full Text] [Related]
8. [Teriparatide (human recombinant 1-34 parathyroid hormone)--a new treatment regimen for severe osteoporosis].
Vestergaard P; Nielsen LR; Mosekilde L
Ugeskr Laeger; 2004 Aug; 166(32):2653-5. PubMed ID: 15347166
[No Abstract] [Full Text] [Related]
9. Normochromic normocytic anemia in a postmenopausal woman with severe osteoporosis treated with intermittent parathyroid hormone.
Anastasilakis AD; Savvides M; Polyzos SA; Georgopoulos C; Delaroudis S
J Bone Miner Metab; 2010; 28(1):108-10. PubMed ID: 19578808
[TBL] [Abstract][Full Text] [Related]
10. Safety of parathyroid hormone for the treatment of osteoporosis.
Miller PD
Curr Osteoporos Rep; 2008 Mar; 6(1):12-6. PubMed ID: 18430395
[TBL] [Abstract][Full Text] [Related]
11. Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis.
Brixen KT; Christensen PM; Ejersted C; Langdahl BL
Basic Clin Pharmacol Toxicol; 2004 Jun; 94(6):260-70. PubMed ID: 15228497
[TBL] [Abstract][Full Text] [Related]
12. Efficacy data on teriparatide (parathyroid hormone) in patients with postmenopausal osteoporosis.
Debiais F
Joint Bone Spine; 2003 Dec; 70(6):465-70. PubMed ID: 14667554
[TBL] [Abstract][Full Text] [Related]
13. Investigational anabolic agents for the treatment of osteoporosis: an update on recent developments.
Dede AD; Makras P; Anastasilakis AD
Expert Opin Investig Drugs; 2017 Oct; 26(10):1137-1144. PubMed ID: 28836858
[TBL] [Abstract][Full Text] [Related]
14. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
Neer RM; Arnaud CD; Zanchetta JR; Prince R; Gaich GA; Reginster JY; Hodsman AB; Eriksen EF; Ish-Shalom S; Genant HK; Wang O; Mitlak BH
N Engl J Med; 2001 May; 344(19):1434-41. PubMed ID: 11346808
[TBL] [Abstract][Full Text] [Related]
15. Clinical use of teriparatide in the real world: initial insights.
Miller PD; Bilezikian JP; Deal C; Harris ST; Ci RP
Endocr Pract; 2004; 10(2):139-48. PubMed ID: 15256332
[TBL] [Abstract][Full Text] [Related]
16. [Teriparatide: human recombinant parathyroid hormone (1-34) as a daily subcutaneous injection].
Sowa H; Hamaya E; Yamamoto T
Clin Calcium; 2011 Jan; 21(1):9-16. PubMed ID: 21187589
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic agents for disorders of bone and calcium metabolism--Teriparatide, parathyroid hormone (1-34) as a daily subcutaneous injection].
Hashimoto Y; Wakayama N; Miyauchi A
Clin Calcium; 2007 Jan; 17(1):48-55. PubMed ID: 17211093
[TBL] [Abstract][Full Text] [Related]
18. Daily nasal spray of hPTH(1-34) for 3 months increases bone mass in osteoporotic subjects: a pilot study.
Matsumoto T; Shiraki M; Hagino H; Iinuma H; Nakamura T
Osteoporos Int; 2006 Oct; 17(10):1532-8. PubMed ID: 16767525
[TBL] [Abstract][Full Text] [Related]
19. Effects of abaloparatide, a human parathyroid hormone-related peptide analog, on bone mineral density in postmenopausal women with osteoporosis.
Leder BZ; O'Dea LS; Zanchetta JR; Kumar P; Banks K; McKay K; Lyttle CR; Hattersley G
J Clin Endocrinol Metab; 2015 Feb; 100(2):697-706. PubMed ID: 25393645
[TBL] [Abstract][Full Text] [Related]
20. Anabolic effects of recombinant human parathyroid hormone (1 - 84) and synthetic human parathyroid hormone (1 - 34) on the mandibles of osteopenic ovariectomized rats with maxillary molar extraction.
Kawane T; Takahashi S; Saitoh H; Okamoto H; Kubodera N; Horiuchi N
Horm Metab Res; 2002 Jun; 34(6):293-302. PubMed ID: 12173069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
